Cumberland Pharmaceuticals Stock Price, News & Analysis (NASDAQ:CPIX)

$7.11 -0.01 (-0.14 %)
(As of 12/17/2017 04:00 PM ET)
Previous Close$7.11
Today's Range$7.11 - $7.46
52-Week Range$5.16 - $7.96
Volume6,889 shs
Average Volume6,553 shs
Market Capitalization$111.97 million
P/E RatioN/A
Dividend YieldN/A
Beta0.86

About Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals logoCumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Receive CPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Generic Pharmaceuticals
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNASDAQ:CPIX
CUSIP23077010
Phone615-255-0068

Debt

Debt-to-Equity Ratio0.12%
Current Ratio4.18%
Quick Ratio3.81%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$33.03 million
Price / Sales3.39
Cash Flow$0.21 per share
Price / Cash34.30
Book Value$4.52 per share
Price / Book1.57

Profitability

Trailing EPS($0.50)
Net Income$-940,000.00
Net Margins-20.55%
Return on Equity-0.52%
Return on Assets-0.39%

Miscellaneous

Employees82
Outstanding Shares15,750,000

Cumberland Pharmaceuticals (NASDAQ:CPIX) Frequently Asked Questions

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) issued its earnings results on Monday, May, 15th. The specialty pharmaceutical company reported ($0.08) earnings per share for the quarter. The specialty pharmaceutical company earned $9.64 million during the quarter. Cumberland Pharmaceuticals had a negative return on equity of 0.52% and a negative net margin of 20.55%. View Cumberland Pharmaceuticals' Earnings History.

When will Cumberland Pharmaceuticals make its next earnings announcement?

Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, March, 6th 2018. View Earnings Estimates for Cumberland Pharmaceuticals.

Who are some of Cumberland Pharmaceuticals' key competitors?

Who are Cumberland Pharmaceuticals' key executives?

Cumberland Pharmaceuticals' management team includes the folowing people:

  • A. J. Kazimi, Chairman of the Board, Principal Executive Officer (Age 56)
  • Michael Bonner, Senior Director Finance and Accounting and Chief Financial Officer
  • Martin E. Cearnal, Senior Vice President, Chief Commercial Officer, Director (Age 70)
  • Leo Pavliv, Senior Vice President - Operations, Chief Development Officer (Age 55)
  • James L. Herman, Vice President - National Accounts, Chief Compliance Officer (Age 59)
  • Amy Dix Rock Ph.D., Vice President - Regulatory & Scientific Affairs
  • Gordon R. Bernard M.D., Independent Director (Age 62)
  • Jonathan Griggs, Independent Director (Age 80)
  • Joey A. Jacobs, Independent Director (Age 62)
  • James R Jones, Independent Director (Age 68)

Who owns Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Stonepine Capital Management LLC (8.08%), New York State Common Retirement Fund (1.57%) and Essex Investment Management Co. LLC (0.22%). Company insiders that own Cumberland Pharmaceuticals stock include Kenneth Krogulski, Michael Bonner and Thomas R Lawrence. View Institutional Ownership Trends for Cumberland Pharmaceuticals.

Who sold Cumberland Pharmaceuticals stock? Who is selling Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund. View Insider Buying and Selling for Cumberland Pharmaceuticals.

Who bought Cumberland Pharmaceuticals stock? Who is buying Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC and Essex Investment Management Co. LLC. Company insiders that have bought Cumberland Pharmaceuticals stock in the last two years include Kenneth Krogulski and Michael Bonner. View Insider Buying and Selling for Cumberland Pharmaceuticals.

How do I buy Cumberland Pharmaceuticals stock?

Shares of Cumberland Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cumberland Pharmaceuticals' stock price today?

One share of Cumberland Pharmaceuticals stock can currently be purchased for approximately $7.11.

How big of a company is Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals has a market capitalization of $111.97 million and generates $33.03 million in revenue each year. The specialty pharmaceutical company earns $-940,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Cumberland Pharmaceuticals employs 82 workers across the globe.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The specialty pharmaceutical company can be reached via phone at 615-255-0068 or via email at [email protected]


MarketBeat Community Rating for Cumberland Pharmaceuticals (CPIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Cumberland Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cumberland Pharmaceuticals (NASDAQ:CPIX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Cumberland Pharmaceuticals (NASDAQ:CPIX) Earnings History and Estimates Chart

Earnings by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ CPIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/5/2018N/AView Earnings Details
8/8/2017Q2 2017($0.07)$8.67 millionViewListenView Earnings Details
5/15/2017Q1 2017($0.08)$9.64 millionViewN/AView Earnings Details
3/7/2017Q4 2016$0.05$9.08 millionViewListenView Earnings Details
11/1/2016Q316$0.01$7.90 million$8.80 millionViewN/AView Earnings Details
5/10/2016Q116$0.02$8.70 million$7.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$8.10 million$8.70 millionViewN/AView Earnings Details
5/13/2014Q114$0.02$10.26 million$8.09 millionViewN/AView Earnings Details
3/4/2014Q4 13$0.05($0.08)ViewN/AView Earnings Details
11/5/2013Q313($0.04)$7.60 million$6.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.02($0.03)$9.40 million$7.10 millionViewN/AView Earnings Details
5/2/2013Q113$0.05$0.05$10.00 million$10.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.14$0.09$13.87 million$13.70 millionViewN/AView Earnings Details
11/1/2012Q312$0.09$0.10$13.05 million$12.50 millionViewN/AView Earnings Details
8/2/2012$0.07$0.09ViewN/AView Earnings Details
5/3/2012$0.05$0.02ViewN/AView Earnings Details
2/29/2012$0.05$0.04ViewN/AView Earnings Details
11/3/2011$0.06$0.09ViewN/AView Earnings Details
8/4/2011$0.04$0.11ViewN/AView Earnings Details
5/5/2011$0.03$0.03ViewN/AView Earnings Details
3/8/2011$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Cumberland Pharmaceuticals (NASDAQ:CPIX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cumberland Pharmaceuticals (NASDAQ:CPIX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cumberland Pharmaceuticals (NASDAQ CPIX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 38.00%
Institutional Ownership Percentage: 34.44%
Insider Trades by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Insider Trades by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ CPIX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2017Michael BonnerCFOBuy250$7.81$1,952.50View SEC Filing  
11/20/2017Kenneth KrogulskiDirectorBuy3,300$7.55$24,915.00View SEC Filing  
8/23/2017Michael BonnerCFOBuy500$6.72$3,360.00View SEC Filing  
5/31/2017Michael BonnerCFOBuy300$6.95$2,085.00View SEC Filing  
4/7/2017Thomas R. LawrenceDirectorSell6,000$6.40$38,400.00View SEC Filing  
3/23/2017Michael BonnerCFOBuy900$6.42$5,778.00View SEC Filing  
11/17/2016Michael BonnerCFOBuy900$5.50$4,950.00View SEC Filing  
8/17/2016Thomas R LawrenceDirectorSell3,000$4.60$13,800.00View SEC Filing  
5/26/2016Thomas R LawrenceDirectorSell3,000$4.55$13,650.00View SEC Filing  
11/19/2015Thomas R LawrenceDirectorSell4,000$5.61$22,440.00View SEC Filing  
3/19/2015Thomas R LawrenceDirectorSell6,000$6.95$41,700.00View SEC Filing  
11/20/2014Thomas R LawrenceDirectorSell10,000$5.12$51,200.00View SEC Filing  
8/21/2014Thomas R LawrenceDirectorSell15,000$5.08$76,200.00View SEC Filing  
3/19/2014Thomas LawrenceDirectorSell20,000$4.54$90,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cumberland Pharmaceuticals (NASDAQ CPIX) News Headlines

Source:
DateHeadline
Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?
finance.yahoo.com - December 15 at 5:28 PM
Cumberland Pharmaceuticals (CPIX) Downgraded to Sell at ValuEngineCumberland Pharmaceuticals (CPIX) Downgraded to Sell at ValuEngine
www.americanbankingnews.com - December 4 at 10:26 PM
Insider Buying: Cumberland Pharmaceuticals, Inc. (CPIX) Director Acquires 3,300 Shares of StockInsider Buying: Cumberland Pharmaceuticals, Inc. (CPIX) Director Acquires 3,300 Shares of Stock
www.americanbankingnews.com - November 24 at 7:52 PM
Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?
finance.yahoo.com - November 24 at 11:03 AM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 14, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 14, 2017
finance.yahoo.com - November 14 at 5:55 PM
Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 13 at 9:36 PM
Edited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 10:07 PM
Cumberland Pharmaceuticals Inc. to Host Earnings CallCumberland Pharmaceuticals Inc. to Host Earnings Call
finance.yahoo.com - November 7 at 10:55 PM
Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third QuarterCumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter
finance.yahoo.com - November 7 at 10:55 PM
Cumberland reports 3Q lossCumberland reports 3Q loss
finance.yahoo.com - November 7 at 10:55 PM
Cumberland Pharmaceuticals Inc. (CPIX) Issues  Earnings ResultsCumberland Pharmaceuticals Inc. (CPIX) Issues Earnings Results
www.americanbankingnews.com - November 7 at 6:34 PM
Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on TuesdayCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - November 1 at 10:48 AM
Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial ResultsCumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results
finance.yahoo.com - October 31 at 6:38 PM
Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?
finance.yahoo.com - October 30 at 4:17 PM
Cumberland Pharmaceuticals Inc (CPIX): Time For A Financial Health CheckCumberland Pharmaceuticals Inc (CPIX): Time For A Financial Health Check
finance.yahoo.com - October 27 at 10:33 PM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017
finance.yahoo.com - October 25 at 7:04 PM
Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on MondayCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - October 23 at 10:56 AM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 9, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 6:02 PM
Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 5:41 PM
Cumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology InterventionCumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology Intervention
finance.yahoo.com - September 25 at 12:16 PM
What Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?What Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?
finance.yahoo.com - September 13 at 6:41 PM
Edited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMTEdited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 12 at 3:55 AM
Cumberland reports 2Q lossCumberland reports 2Q loss
finance.yahoo.com - August 8 at 10:15 PM
Cumberland Pharmaceuticals Inc. (CPIX) Releases  Earnings ResultsCumberland Pharmaceuticals Inc. (CPIX) Releases Earnings Results
www.americanbankingnews.com - August 8 at 9:30 PM
Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive QuarterCumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter
finance.yahoo.com - August 8 at 5:13 PM
Cumberland Pharmaceuticals Inc. (CPIX) Scheduled to Post Quarterly Earnings on TuesdayCumberland Pharmaceuticals Inc. (CPIX) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 3 at 10:40 AM
Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial ResultsCumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results
finance.yahoo.com - August 1 at 6:08 PM
Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient SupportCumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support
finance.yahoo.com - July 31 at 5:23 PM
Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on MondayCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 24 at 8:49 AM
Financial Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) and Merus Labs International (MSLI)Financial Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) and Merus Labs International (MSLI)
www.americanbankingnews.com - July 17 at 10:27 AM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017
finance.yahoo.com - July 12 at 6:10 PM
Cumberland Pharmaceuticals (CPIX) Reports Significant Post Surgical Pain Reduction and Decrease in Opioid Use from Caldolor®Cumberland Pharmaceuticals (CPIX) Reports Significant Post Surgical Pain Reduction and Decrease in Opioid Use from Caldolor®
www.streetinsider.com - March 28 at 4:14 PM
CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrants Certifying Accountant, Financial StatemeCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Stateme
biz.yahoo.com - March 22 at 9:35 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland ...SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland ...
www.businesswire.com - March 18 at 1:56 AM
CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrants Certifying AccountantCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
biz.yahoo.com - March 16 at 5:49 PM
CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual ReportCUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 13 at 12:28 PM
CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - March 10 at 5:32 PM
Q4 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market CloseQ4 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - March 7 at 12:16 PM
Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And PharmacokineticsCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
www.prnewswire.com - February 7 at 5:35 PM
Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And PharmacokineticsCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
www.prnewswire.com - February 7 at 5:35 PM
U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals Victory In Patent Litigation CaseU.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case
us.rd.yahoo.com - January 30 at 5:19 PM
8:17 am Cumberland Pharma announces the U.S. Court of Appeals for the Federal Circuit ruled in favor of Cumberland in a patent case associated with its Acetadote product, rejecting Mylans (<a href="/q?s=myl" name="myl">MYL</a>) challenge o8:17 am Cumberland Pharma announces the U.S. Court of Appeals for the Federal Circuit ruled in favor of Cumberland in a patent case associated with its Acetadote product, rejecting Mylan's (MYL) challenge o
us.rd.yahoo.com - January 30 at 5:19 PM
CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other EventsCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
biz.yahoo.com - January 13 at 5:11 PM
Cumberland Pharmaceuticals (CPIX), Clinigen Enter Pact for Commercialization of TotectCumberland Pharmaceuticals (CPIX), Clinigen Enter Pact for Commercialization of Totect
www.streetinsider.com - January 9 at 10:37 PM
Q3 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market CloseQ3 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - November 1 at 8:33 AM
Cumberland Pharmaceuticals (CPIX) Commences Shipments of Ethyol to U.S. WholesalersCumberland Pharmaceuticals (CPIX) Commences Shipments of Ethyol to U.S. Wholesalers
www.streetinsider.com - August 24 at 9:37 AM
Q2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market CloseQ2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - August 2 at 9:12 AM
Q1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market CloseQ1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - May 10 at 7:07 AM

SEC Filings

Cumberland Pharmaceuticals (NASDAQ:CPIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cumberland Pharmaceuticals (NASDAQ:CPIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cumberland Pharmaceuticals (NASDAQ CPIX) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.